GEN Exclusives

More »
Insight & Intelligence™

Related to Novartis Pays Enanta $34M Up Front for Worldwide Rights to HCV NS5A Inhibitors

  • Page 1 of 2 (36 items) 1 2  Last

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Value-Pricing Cancer Drugs

Do you think all new cancer drugs awaiting approval should undergo value-pricing?

More »